Zhang S, Cui R
Department of Cardiology, Heilongjiang Provincial Hospital, Harbin, Heilongjiang, P.R. China.
Eur Rev Med Pharmacol Sci. 2020 Sep;24(18):9235. doi: 10.26355/eurrev_202009_22989.
Since this article has been suspected of research misconduct and the corresponding authors did not respond to our request to prove originality of data and figures, "The targeted regulation of miR-26a on PTEN-PI3K/AKT signaling pathway in myocardial fibrosis after myocardial infarction, by S. Zhang, R. Cui, published in Eur Rev Med Pharmacol Sci 2018; 22 (2): 523-531-DOI: 10.26355/eurrev_201801_14205-PMID: 29424913" has been withdrawn. The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/14205.
由于本文被怀疑存在研究不当行为，且通讯作者未回应我们要求证明数据和图表原创性的请求，S. Zhang、R. Cui发表于《欧洲医学与药理学评论》2018年第22卷第2期，第523 - 531页，DOI: 10.26355/eurrev_201801_14205，PMID: 29424913的文章《心肌梗死后心肌纤维化中miR - 26a对PTEN - PI3K/AKT信号通路的靶向调控》已被撤回。出版方对由此可能造成的不便表示歉意。https://www.europeanreview.org/article/14205
